Peter Guenter
Direktor/Vorstandsmitglied bei GALAPAGOS NV
Vermögen: 56 614 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Peter Guenter
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
47
| Public Company | Pharmaceuticals: Major | 47 |
30
| Public Company | Biotechnology | 30 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.
26
| Non-Profit Organization | Miscellaneous Commercial Services | 26 |
| Public Company | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Peter Guenter
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chairman Chairman Corporate Officer/Principal Director/Board Member | |
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal President Corporate Officer/Principal Director/Board Member | |
| Technische Universität Darmstadt | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Operating Officer Sales & Marketing Chief Executive Officer President Corporate Officer/Principal | |
Industriegewerkschaft Bergbau Chemie Energie
 Industriegewerkschaft Bergbau Chemie Energie Miscellaneous Commercial ServicesCommercial Services Industriegewerkschaft Bergbau Chemie Energie operates as a trade union. The private company is based in Hannover, Germany. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
| UCB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Corporate Officer/Principal | |
| Merck Healthcare KGaA | Corporate Officer/Principal Chairman Director/Board Member | ||
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal President President | |
Verband der Chemischen Industrie eV
 Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| Merck Life Science KGaA | Director/Board Member Chairman Director/Board Member | ||
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | Food: Specialty/Candy | Chief Executive Officer Chief Executive Officer Director/Board Member | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Executive Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Chief Executive Officer Public Communications Contact Investor Relations Contact | |
| SANOFI | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Doctorate Degree Undergraduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Undergraduate Degree | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Masters Business Admin | |
NeRRe Therapeutics Ltd.
 NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Medical Distributors | Director/Board Member Chief Executive Officer | |
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| Leem | Founder Director/Board Member | ||
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| University of Oxford | College/University | Corporate Officer/Principal Graduate Degree | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Verband Forschender Arzneimittelhersteller eV
 Verband Forschender Arzneimittelhersteller eV Miscellaneous Commercial ServicesCommercial Services Verband Forschender Arzneimittelhersteller eV, founded in 1994, is an association of researching pharmaceutical companies in Germany. The private company is based in Berlin, Germany. The German company's main focus is on the drugs and therapies currently being researched in the industry. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Chairman | |
| SAP SE | Packaged Software | Corporate Officer/Principal Director/Board Member | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member President | |
Zentiva NV
 Zentiva NV Pharmaceuticals: GenericHealth Technology Zentiva NV manufactures and markets branded generic pharmaceutical products. The company is headquartered in Amsterdam, the Netherlands. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
The Innovative Medicines Initiative
 The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Drugstore Chains | Chairman Director/Board Member | |
Zentiva Group as
 Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Hochschule für Wirtschaft und Recht Berlin | College/University | Undergraduate Degree Undergraduate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Aleta Biotherapeutics, Inc.
 Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aleta Biotherapeutics, Inc. engages in the immuno-oncology service that focuses on transforming cellular therapeutics. It allows broad spectrum of cancer indication to be targeted including currently intractable solid tumors. The company was founded by Paul Rennert and Roy Lobb and is headquartered in Natick, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Director/Board Member Chairman | |
| Merck Healthcare | Chief Operating Officer Chief Executive Officer |
Statistik
International
| Deutschland | 15 |
| Vereinigte Staaten | 14 |
| Vereinigtes Königreich | 7 |
| Schweiz | 6 |
| Frankreich | 5 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Consumer Non-Durables | 2 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 477 |
| Corporate Officer/Principal | 248 |
| Chief Executive Officer | 176 |
| Chairman | 111 |
| Independent Dir/Board Member | 106 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Helene von Roeder | 84 |
| Raj Bhikhu Parekh | 50 |
| Enrique de Leyva Pérez | 44 |
| Marie-Laure Jeanne Antoinette Pochon | 36 |
| Dieter Weinand | 32 |
| Joseph Jimenez | 32 |
| Marc M. P. de Garidel | 31 |
| Ian Read | 29 |
| Wolfgang Heinz Büchele | 28 |
| Ulf Arne Wiinberg | 26 |
| Peter Andersen | 26 |
| Stefan Oschmann | 23 |
| Jérôme Contamine | 23 |
| Belén Garijo López | 22 |
| Andreas Fibig | 21 |
- Börse
- Insiders
- Peter Guenter
- Unternehmensverbindungen
